Sun H, Yan H, Yan Z, Zhu Y, et al. Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT. Ann Hematol 2022 Nov 24. doi: 10.1007/s00277-022-05047.
PMID: 36434435